Products / CNS APIs

CNS APIs

Inke develops and manufactures API ingredients for use in CNS therapies, as a subsidiary of Neuraxpharm,
a European leader in pharmaceutical products for the central nervous system (CNS)

API	Indication	Micronised / PSD	CEP	EU DMF	US DMF	JP DMF	KR DMF
Asenapine^p	Schizophrenia and acute mania	•
Brexpiprazole	Schizophrenia and major depressive disorders
Brivaracetam	Antiepileptic
Clomethiazole	Insomnia		•
Eletriptan HBr^p	Migraine	•				•
Olanzapine^p	Schizophrenia, psychosis		•		•
Olanzapine pamoate (sterile)	Schizophrenia, psychosis	•
Quetiapine hemifumarate^p	Schizophrenia, psychosis		•			•	•
Risperidone^p	Schizophrenia, psychosis	•		•	•		•
Rizatriptan benzoate^p	Migraine	•	•		•
Tetrabenazine	Parkinson disease
Tetrabenazine (+)	Parkinson disease
Zolmitriptan^p	Migraine	•	•		•

INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain marketing authorisation. In particular, these products are developed for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC, i.e activities carried out to obtain marketing authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.